Charles Schwab’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $123M | Sell |
2,261,816
-56,420
| -2% | -$2.75M | 0.02% | 667 |
|
|
2026
Q1 | $99.4M | Buy |
2,318,236
+81,598
| +4% | +$3.51M | 0.02% | 722 |
|
|
2025
Q4 | $98M | Sell |
2,236,638
-13,169
| -0.6% | -$545K | 0.02% | 741 |
|
|
2025
Q3 | $92.9M | Sell |
2,249,807
-986,268
| -30% | -$39.6M | 0.01% | 754 |
|
|
2025
Q2 | $143M | Sell |
3,236,075
-85,332
| -3% | -$3.41M | 0.02% | 518 |
|
|
2025
Q1 | $123M | Buy |
3,321,407
+69,054
| +2% | +$2.46M | 0.02% | 555 |
|
|
2024
Q4 | $108M | Sell |
3,252,353
-21,267
| -0.6% | -$690K | 0.02% | 619 |
|
|
2024
Q3 | $85M | Sell |
3,273,620
-33,071
| -1% | -$822K | 0.02% | 764 |
|
|
2024
Q2 | $74.3M | Sell |
3,306,691
-61,934
| -2% | -$1.37M | 0.01% | 789 |
|
|
2024
Q1 | $79.9M | Buy |
3,368,625
+4,145
| +0.1% | +$92.1K | 0.02% | 723 |
|
|
2023
Q4 | $80.7M | Buy |
3,364,480
+28,840
| +0.9% | +$627K | 0.02% | 669 |
|
|
2023
Q3 | $72.9M | Buy |
3,335,640
+58,320
| +2% | +$1.22M | 0.02% | 656 |
|
|
2023
Q2 | $62.6M | Buy |
3,277,320
+39,471
| +1% | +$761K | 0.02% | 729 |
|
|
2023
Q1 | $62.8M | Sell |
3,237,849
-142,853
| -4% | -$2.49M | 0.02% | 685 |
|
|
2022
Q4 | $54.2M | Buy |
3,380,702
+118,600
| +4% | +$1.93M | 0.02% | 755 |
|
|
2022
Q3 | $51.1M | Buy |
3,262,102
+208,309
| +7% | +$4.02M | 0.02% | 743 |
|
|
2022
Q2 | $63.6M | Buy |
3,053,793
+101,090
| +3% | +$2.08M | 0.02% | 634 |
|
|
2022
Q1 | $66.9M | Buy |
2,952,703
+243,453
| +9% | +$4.76M | 0.02% | 696 |
|
|
2021
Q4 | $49.5M | Buy |
2,709,250
+150,490
| +6% | +$2.88M | 0.01% | 907 |
|
|
2021
Q3 | $54.1M | Buy |
2,558,760
+877,233
| +52% | +$16.3M | 0.02% | 810 |
|
|
2021
Q2 | $30.6M | Buy |
1,681,527
+95,518
| +6% | +$2.23M | 0.01% | 1228 |
|
|
2021
Q1 | $35.8M | Buy |
1,586,009
+50,237
| +3% | +$1.13M | 0.01% | 1060 |
|
|
2020
Q4 | $30.8M | Buy |
1,535,772
+21,569
| +1% | +$452K | 0.01% | 1082 |
|
|
2020
Q3 | $37M | Buy |
1,514,203
+25,620
| +2% | +$598K | 0.02% | 821 |
|
|
2020
Q2 | $35.3M | Buy |
1,488,583
+38,650
| +3% | +$896K | 0.02% | 791 |
|
|
2020
Q1 | $25M | Buy |
1,449,933
+30,351
| +2% | +$555K | 0.01% | 862 |
|
|
2019
Q4 | $25M | Sell |
1,419,582
-14,411
| -1% | -$244K | 0.01% | 1060 |
|
|
2019
Q3 | $25.4M | Buy |
1,433,993
+101,286
| +8% | +$2.05M | 0.02% | 987 |
|
|
2019
Q2 | $28.5M | Buy |
1,332,707
+57,570
| +5% | +$1.21M | 0.02% | 903 |
|
|
2019
Q1 | $30.3M | Buy |
1,275,137
+91,756
| +8% | +$2.09M | 0.02% | 857 |
|
|
2018
Q4 | $23.3M | Buy |
1,183,381
+39,471
| +3% | +$704K | 0.02% | 896 |
|
|
2018
Q3 | $20.3M | Buy |
1,143,910
+124,613
| +12% | +$2.43M | 0.01% | 1133 |
|
|
2018
Q2 | $21.9M | Buy |
1,019,297
+47,730
| +5% | +$987K | 0.02% | 1010 |
|
|
2018
Q1 | $21.5M | Sell |
971,567
-51,361
| -5% | -$1.42M | 0.02% | 948 |
|
|
2017
Q4 | $31.1M | Buy |
1,022,928
+2,449
| +0.2% | +$65.1K | 0.02% | 681 |
|
|
2017
Q3 | $24.7M | Buy |
1,020,479
+164,839
| +19% | +$4.39M | 0.02% | 767 |
|
|
2017
Q2 | $21.1M | Sell |
855,640
-308,349
| -26% | -$6.52M | 0.02% | 819 |
|
|
2017
Q1 | $25.2M | Buy |
1,163,989
+261,894
| +29% | +$5.33M | 0.03% | 676 |
|
|
2016
Q4 | $13.5M | Buy |
902,095
+58,268
| +7% | +$841K | 0.01% | 1045 |
|
|
2016
Q3 | $10.8M | Buy |
843,827
+47,812
| +6% | +$517K | 0.01% | 1115 |
|
|
2016
Q2 | $6.22M | Buy |
796,015
+15,522
| +2% | +$89.4K | 0.01% | 1421 |
|
|
2016
Q1 | $3.12M | Buy |
780,493
+16,903
| +2% | +$71.5K | ﹤0.01% | 1804 |
|
|
2015
Q4 | $4.31M | Buy |
763,590
+49,046
| +7% | +$274K | 0.01% | 1623 |
|
|
2015
Q3 | $4.01M | Buy |
714,544
+78,237
| +12% | +$426K | 0.01% | 1617 |
|
|
2015
Q2 | $2.39M | Buy |
636,307
+18,582
| +3% | +$60.4K | ﹤0.01% | 1989 |
|
|
2015
Q1 | $1.59M | Buy |
617,725
+114,212
| +23% | +$265K | ﹤0.01% | 2178 |
|
|
2014
Q4 | $726K | Buy |
503,513
+12,078
| +2% | +$18.8K | ﹤0.01% | 2480 |
|
|
2014
Q3 | $752K | Sell |
491,435
-13,642
| -3% | -$43.8K | ﹤0.01% | 2433 |
|
|
2014
Q2 | $1.71M | Sell |
505,077
-1,776
| -0.4% | -$6.13K | ﹤0.01% | 2056 |
|
|
2014
Q1 | $1.79M | Buy |
506,853
+29,604
| +6% | +$202K | ﹤0.01% | 2016 |
|
|
2013
Q4 | $2.93M | Buy |
477,249
+37,680
| +9% | +$208K | 0.01% | 1659 |
|
|
2013
Q3 | $2.6M | Buy |
439,569
+22,014
| +5% | +$114K | 0.01% | 1680 |
|
|
2013
Q2 | $1.95M | Buy |
+417,555
| New | +$1.98M | ﹤0.01% | 1774 |
|
Other funds holding EXEL
FCM
Charles Schwab's EXEL Position: Q2 2026 in Review
Charles Schwab reduced its Exelixis (EXEL) stake by 2.4% in Q2 2026, selling an estimated $2.75M and leaving 2,261,816 shares worth $123M. The position accounts for 0.02% of the portfolio, ranked #667.
Charles Schwab first reported a position in EXEL in Q2 2013 and has held it in 53 quarters since. The position peaked at $143M in Q2 2025. 754 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.
- Charles Schwab held 2,261,816 shares of Exelixis worth $123M as of Q2 2026.
- Charles Schwab sold 56,420 Exelixis shares in Q2 2026, an estimated $2.75M.
- Exelixis made up 0.02% of Charles Schwab's portfolio in Q2 2026, its #667 holding.
- Charles Schwab first reported a position in Exelixis in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's Exelixis position peaked at $143M in Q2 2025.
- 754 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.